View in EDS HTML Full Text PDF Full Text

How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature.

Saved in:
Bibliographic Details
Title: How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature.
Authors: Alan, Ozkan1 ozkan.alan@hotmail.com, Kuzhan, Okan2, Koca, Sinan3, Telli, Tugba Akin1, Basoglu, Tugba1, Ercelep, Ozlem1, Filinte, Deniz4, Sengul, Yildiz5, Arikan, Huseyin6, Kaya, Serap1, Babacan, Nalan Akgul1, Dane, Faysal1, Yumuk, Perran Fulden1
Source: Journal of Oncology Pharmacy Practice. Jun2020, Vol. 26 Issue 4, p1011-1018. 8p. 2 Color Photographs, 2 Black and White Photographs, 2 Charts.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 143389556
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Alan%2C+Ozkan%22">Alan, Ozkan</searchLink><relatesTo>1</relatesTo><i> ozkan.alan@hotmail.com</i><br /><searchLink fieldCode="AR" term="%22Kuzhan%2C+Okan%22">Kuzhan, Okan</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Koca%2C+Sinan%22">Koca, Sinan</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Telli%2C+Tugba+Akin%22">Telli, Tugba Akin</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Basoglu%2C+Tugba%22">Basoglu, Tugba</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Ercelep%2C+Ozlem%22">Ercelep, Ozlem</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Filinte%2C+Deniz%22">Filinte, Deniz</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Sengul%2C+Yildiz%22">Sengul, Yildiz</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Arikan%2C+Huseyin%22">Arikan, Huseyin</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Kaya%2C+Serap%22">Kaya, Serap</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Babacan%2C+Nalan+Akgul%22">Babacan, Nalan Akgul</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Dane%2C+Faysal%22">Dane, Faysal</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Yumuk%2C+Perran+Fulden%22">Yumuk, Perran Fulden</searchLink><relatesTo>1</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Journal+of+Oncology+Pharmacy+Practice%22">Journal of Oncology Pharmacy Practice</searchLink>. Jun2020, Vol. 26 Issue 4, p1011-1018. 8p. 2 Color Photographs, 2 Black and White Photographs, 2 Charts.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=143389556
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/1078155219879757
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 8
        StartPage: 1011
    Titles:
      – TitleFull: How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Alan, Ozkan
      – PersonEntity:
          Name:
            NameFull: Kuzhan, Okan
      – PersonEntity:
          Name:
            NameFull: Koca, Sinan
      – PersonEntity:
          Name:
            NameFull: Telli, Tugba Akin
      – PersonEntity:
          Name:
            NameFull: Basoglu, Tugba
      – PersonEntity:
          Name:
            NameFull: Ercelep, Ozlem
      – PersonEntity:
          Name:
            NameFull: Filinte, Deniz
      – PersonEntity:
          Name:
            NameFull: Sengul, Yildiz
      – PersonEntity:
          Name:
            NameFull: Arikan, Huseyin
      – PersonEntity:
          Name:
            NameFull: Kaya, Serap
      – PersonEntity:
          Name:
            NameFull: Babacan, Nalan Akgul
      – PersonEntity:
          Name:
            NameFull: Dane, Faysal
      – PersonEntity:
          Name:
            NameFull: Yumuk, Perran Fulden
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: Jun2020
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 10781552
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Journal of Oncology Pharmacy Practice
              Type: main
ResultId 1